174P First-in-human study of NGM707, an ILT2/ILT4 dual antagonist antibody in advanced or metastatic solid tumors: Preliminary monotherapy dose escalation data A. Naing, J.S. Wang, M.R. Sharma, D. Sommerhalder,L. Gandhi,D-Y. Oh, Y. Jiang, J. Michalski, J. Lee, K. Zhou, N. Taylor, L. Yan, J.M. Roda, L. Blum, L. Ling,I. Mikaelian, A.M. Depaoli, V. Hanes, D.D. Kaplan, H.D. LieuImmuno-Oncology and Technology（2022）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
